MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy

FEBS Letters

Volumn 586, Issue 1, 2012, Pages 20-26

  Zhang, Zheng ^a   Luo, Xiaomei ^b   Ding, Songtao ^a   Chen, Junxia ^a   Chen, Tao ^a   Chen, Xin ^a   Zha, He ^a   Yao, Li ^a   He, Xiaoyan ^a   Peng, Huimin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Crops Hospital of Armed Police Force   (China)

Author keywords

Cell proliferation; Diabetic nephropathy; MicroRNA

Indexed keywords

MICRORNA; MICRORNA 451; MITOGEN ACTIVATED PROTEIN KINASE P38; TYROSINE 3 MONOOXYGENASE TRYPTOPHAN 5 MONOOXYGENASE ACTIVATION PROTEIN ZETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC REGULATION; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KIDNEY HYPERTROPHY; MALE; MESANGIUM CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; 3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL PROLIFERATION; CONSERVED SEQUENCE; DIABETIC NEPHROPATHIES; MALE; MAP KINASE SIGNALING SYSTEM; MESANGIAL CELLS; MICE; MICRORNAS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84655163918     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.07.042     Document Type: Article

References (29)

1. R.M. Mason, and N.A. Wahab Extracellular matrix metabolism in diabetic nephropathy J. Am. Soc. Nephrol. 14 2003 1358 1373 (Pubitemid 36519197)
2. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20 (Pubitemid 40094598)
3. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl Identification of novel genes coding for small expressed RNAs Science 294 2004 853 858
4. M.N. Poy, L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, P.E. Macdonald, S. Pfeffer, T. Tuschl, N. Rajewsky, P. Rorsman, and M. Stoffel A pancreatic islet-specific microRNA regulates insulin secretion Nature 432 2004 226 230 (Pubitemid 39545853)
5. A. He, L. Zhu, N. Gupta, Y. Chang, and F. Fang Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes Mol. Endocrinol. 21 2007 2785 2794 (Pubitemid 350035159)
6. J. Xiao, X. Luo, H. Lin, Y. Zhang, Y. Lu, N. Wang, Y. Zhang, B. Yang, and Z. Wang MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts J. Biol. Chem. 282 2007 12363 12367 (Pubitemid 47100573)
7. Z. Zhang, H. Peng, J. Chen, X. Chen, F. Han, X. Xu, X. He, and N. Yan MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice FEBS Lett. 583 2009 2009 2014
8. M. Megraw, P. Sethupathy, B. Corda, and A.G. Hatzigeorgiou MiRGen: a database for the study of animal microRNA genomic organization and function Nucleic Acids Res. 35 2007 D149 D155
9. X.Y. He, C.Z. Duan, J.X. Chen, X. Ou-Yang, Z. Zhang, C.L. Li, and H.M. Peng Let-7a elevates p21WAF1 levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells FEBS Lett. 583 2009 3501 3507
10. Z. Hua, Q. Lv, W. Ye, C.K. Wong, G. Cai, D. Gu, Y. Ji, C. Zhao, J. Wang, B.B. Yang, and Y. Zhang MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia PLoS ONE 1 2006 e116
11. J.G. Doench, C.P. Petersen, and P.A. Sharp SiRNAs can function as miRNAs Genes Dev. 17 2003 438 442 (Pubitemid 36258757)
12. P.J. Shultz, P.E. DiCorleto, B.J. Silver, and H.E. Abboud Mesangial cells express PDGF mRNAs and proliferate in response to PDGF Am. J. Physiol. 255 1998 F674 684
13. H. Makino, Y. Miyamoto, K. Sawai, K. More, M. Mukoyama, K. Nakao, Y. Yoshimasa, and S. Suqa Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db Mice and its restoration by pioglitazone Diabetes 55 2006 2747 2756 (Pubitemid 44923673)
14. M. Lin, C.D. Morrison, S. Jones, N. Mohamed, J. Bacher, and C. Plass Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma Int. J. Cancer 125 2009 603 611
15. S.K. Leivonen, A. Rokka, P. Ostling, P. Kohonen, G.L. Corthals, O. Kallioniemi, and M. Perälä Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact Mol. Cell Proteomics 2011 [Epub ahead of print]
16. J.E. Choi, W. Hur, C.K. Jung, L.S. Piao, K. Lyoo, S.W. Hong, S.W. Kim, H.Y. Yoon, and S.K. Yoon Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium Cancer Lett. 303 2011 99 107
17. T. Ogihara, T. Isobe, T. Ichimura, M. Taoke, M. Funaki, H. Sakoda, Y. Onishi, K. Inukai, M. Anai, Y. Fukushima, M. Kikuchi, Y. Yazaki, Y. Oka, and T. Asano 14-3-3 protein binds to insulin receptor substrate-l, one of the binding sites of which is in the phosphotyrosine binding domain J. Biol. Chem. 272 1997 25267 25274 (Pubitemid 27415716)
18. H. Xing, S. Zhang, C. Weinheimer, A. Kovacs, and A.J. Muslin 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades EMBO J. 19 2000 349 358 (Pubitemid 30072605)
19. D.L. Darling, J. Yingling, and A. Wynshaw-Boris Role of 14-3-3 proteins in eukaryotic signaling and development Curr. Top. Dev. Biol. 68 2005 281 315 (Pubitemid 43588860)
20. M.B. Yaffe, K. Rittinger, S. Volinia, P.R. Caron, A. Aitken, H. Leffers, S.J. Gamblin, S.J. Smerdon, and L.C. Cantley The structural basis for 14-3-3:phosphopeptide binding specificity Cell 91 1997 961 971 (Pubitemid 28027829)
21. E.C. Lai MicroRNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation Nat. Genet. 30 2002 363 364
22. S.M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, and F.J. Slack RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647 (Pubitemid 40343076)
23. J. Godlewski, A. Bronisz, M.O. Nowicki, E.A. Chiocca, and S. Lawler MicroRNA-451: A conditional switch controlling glioma cell proliferation and migration Cell Cycle 9 2010 2742 2748
24. T. Zarubin, and J. Han Activation and signaling of the p38 MAP kinase pathway Cell Res. 15 2005 11 18 (Pubitemid 41653958)
25. A. Cuenda, and S. Rousseau P38 MAP-kinases pathway regulation, function and role in human diseases Biochim. Biophys. Acta 1773 2007 1358 1375 (Pubitemid 47125981)
26. L.M. Furtado, R. Somwar, G. Sweeney, W. Niu, and A. Klip Activation of the glucose transporter GLUT4 by insulin Biochem. Cell Biol. (Biochimie et Biologie Cellulaire) 80 2002 569 578 (Pubitemid 36124818)
27. H. Kawano, S. Kim, K. Ohta, T. Nakao, H. Miyazaki, T. Nakatani, and H. Iwao Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression J. Am. Soc. Nephrol. 14 2003 584 592 (Pubitemid 36246001)
28. S.W. Kang, S.G. Adler, J. LaPage, and R. Natarajan Glomerular p38 mitogen-activated protein kinase (MAPK) and MAPK kinase (MKK) 3/6 mRNA expression and activity are increased in early diabetic nephropathy Kidney Int. 60 2001 543 552 (Pubitemid 32678898)
29. E. Tsiani, P. Lekas, I.G. Fantus, J. Dlugosz, and C. Whiteside High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor Am. J. Physiol. Endocrinol. Metab. 282 2002 161 169